156 related articles for article (PubMed ID: 30820179)
1. Novel Associations between BRCA1 Variants C.181 T>G (Rs28897672) and Ovarian Crisk in Saudi Females.
Alyahri N; Abdi S; Khan W; Elrobh M; Addar MH; Babay ZA; Alanazi M; Aldaihan S; Shaik J; Arafah M; Parine NR; Warsy A
J Med Biochem; 2019 Mar; 38(1):13-21. PubMed ID: 30820179
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
3. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms in breast cancer susceptibility gene 1 are associated with susceptibility to lung cancer.
Liu D; Gao Y; Li L; Chen H; Bai L; Qu Y; Zhou B; Yan Y; Zhao Y
Oncol Lett; 2021 May; 21(5):424. PubMed ID: 33850565
[TBL] [Abstract][Full Text] [Related]
5. Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family.
Liao Y; Tu C; Song X; Cai L
J Assist Reprod Genet; 2020 Jun; 37(6):1489-1495. PubMed ID: 32356124
[TBL] [Abstract][Full Text] [Related]
6. BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
Li A; Xie R; Zhi Q; Deng Y; Wu Y; Li W; Yang L; Jiao Z; Luo J; Zi Y; Sun G; Zhang J; Shi Y; Liu J
Gynecol Oncol; 2018 Oct; 151(1):145-152. PubMed ID: 30078507
[TBL] [Abstract][Full Text] [Related]
7. A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population.
Mir R; Javid J; Al Balawi IA; Alkharsah KR; Hadi MA; Rahman MA; Hamoud E; Al Alawi Y; Al Zahrani ABM; Abu-Duhier FM
Asian Pac J Cancer Prev; 2018 Mar; 19(3):859-866. PubMed ID: 29582646
[TBL] [Abstract][Full Text] [Related]
8. The Features of
Luo Y; Wu H; Huang Q; Rao H; Yu Z; Zhong Z
Int J Gen Med; 2022; 15():2773-2786. PubMed ID: 35300142
[TBL] [Abstract][Full Text] [Related]
9. Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.
Maistro S; Teixeira N; Encinas G; Katayama ML; Niewiadonski VD; Cabral LG; Ribeiro RM; Gaburo Junior N; de Gouvêa AC; Carraro DM; Sabino EC; Diz MD; Chammas R; de Bock GH; Folgueira MA
BMC Cancer; 2016 Dec; 16(1):934. PubMed ID: 27914478
[TBL] [Abstract][Full Text] [Related]
10. Two novel variants in the 3'UTR of the BRCA1 gene in familial breast and/or ovarian cancer.
Lheureux S; Lambert B; Krieger S; Legros A; Vaur D; Denoyelle C; Berthet P; Poulain L; Hardouin A
Breast Cancer Res Treat; 2011 Feb; 125(3):885-91. PubMed ID: 20848184
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in RAD51 and their relation with breast cancer in Saudi females.
Tulbah S; Alabdulkarim H; Alanazi M; Parine NR; Shaik J; Pathan AA; Al-Amri A; Khan W; Warsy A
Onco Targets Ther; 2016; 9():269-77. PubMed ID: 26834486
[TBL] [Abstract][Full Text] [Related]
12. Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers.
Bjørnslett M; Knappskog S; Lønning PE; Dørum A
BMC Cancer; 2012 Oct; 12():454. PubMed ID: 23039163
[TBL] [Abstract][Full Text] [Related]
13. [No association between MTHFR 677C>T polymorphism and ovarian cancer risk in BRCA1 mutation carriers in Wielkopolska region].
Magnowski P; Seremak-Mrozikiewicz A; Nowak-Markwitz E; Kurzawińska G; Drews K; Spaczyński M
Ginekol Pol; 2010 Jul; 81(7):506-10. PubMed ID: 20825051
[TBL] [Abstract][Full Text] [Related]
14. Lack of association of BRCA1 and BRCA2 variants with breast cancer in an ethnic population of Saudi Arabia, an emerging high-risk area.
Hasan TN; Shafi G; Syed NA; Alsaif MA; Alsaif AA; Alshatwi AA
Asian Pac J Cancer Prev; 2013; 14(10):5671-4. PubMed ID: 24289560
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study.
Tian CQ; Darcy KM; Krivak TC; Deloia JA; Armstrong D; Davis W; Zhao H; Moysich K; Ambrosone CB
Front Oncol; 2013; 3():206. PubMed ID: 23964347
[TBL] [Abstract][Full Text] [Related]
16. Landscape of germline
Ferreyra Y; Rosas G; Cock-Rada AM; Araujo J; Bravo L; Doimi F; Casas J; Clavo MLÁ; Pinto JA; Belmar-López C
Front Oncol; 2023; 13():1227864. PubMed ID: 37664050
[TBL] [Abstract][Full Text] [Related]
17. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
[TBL] [Abstract][Full Text] [Related]
18. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
Kluska A; Balabas A; Paziewska A; Kulecka M; Nowakowska D; Mikula M; Ostrowski J
BMC Med Genomics; 2015 May; 8():19. PubMed ID: 25948282
[TBL] [Abstract][Full Text] [Related]
19. The BRCA1 3'-UTR: 5711+421T/T_5711+1286T/T genotype is a possible breast and ovarian cancer risk factor.
Pongsavee M; Yamkamon V; Dakeng S; O-charoenrat P; Smith DR; Saunders GF; Patmasiriwat P
Genet Test Mol Biomarkers; 2009 Jun; 13(3):307-17. PubMed ID: 19405875
[TBL] [Abstract][Full Text] [Related]
20. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
